Clinical Trial Update: Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Sepsis [NA]

View source ↗

Summary

The pediatric sepsis trial evaluating Efferon LPS NEO for lipopolysaccharide adsorption has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Efferon LPS NEO (lipopolysaccharide adsorption device)

Snippet

Sponsor: Efferon JSC | Conditions: Sepsis, Septic Shock | NA | Status: COMPLETED